The Schwab U.S. Dividend Equity ETF (SCHD) has undergone its annual reconstitution, a process that recalibrates its portfolio based on current market conditions. This year, the fund retained seven of its top ten holdings, including well-known names like Chevron and Coca-Cola, while adding Abbott Laboratories and UnitedHealth Group to the mix. Notably, the overall turnover was significant, with 25 new stocks entering the fund and 22 exiting, reflecting a strategic focus on strong balance sheets and consistent dividend histories.
While there were no drastic sector allocation shifts this year, the ETF did see a slight reduction in cyclical exposure, particularly in energy and materials, with a modest increase in technology holdings. This contrasts with last year’s significant adjustments that bolstered the fund’s performance, suggesting a more stable outlook for SCHD moving forward.
Market professionals should note that despite the changes, the ETF’s core quality and durability remain intact, indicating continued attractiveness for dividend-focused investors without major shifts in performance expectations.
Source: fool.com